D'Onofrio to Headline SAEM18
The Society for Academic Emergency Medicine (SAEM) is pleased to announce that Gail D’Onofrio, MD, MS, professor of emergency medicine and founding chair, Department of Emergency Medicine, Yale School of Medicine, has been named keynote speaker for its annual meeting, in Indianapolis, May 15–18, 2018. Dr. D’Onofrio, who is internationally known for her work in screening emergency department patients for unhealthy alcohol and other drug use, brief intervention, and referral to treatment (SBIRT), will open SAEM18 on Wednesday, May 16, with a keynote address titled The Opioid Crisis: Emergency Physicians as Innovators, Policymakers, and Heroes.
About Dr. D’Onofrio
Dr. D’Onofrio is a recognized leader in emergency medicine and has participated in many National Institutes of Health (NIH) panels. She routinely sits on review committees for the National Institute on Drug Abuse (NIDA), the National Advisory Council on Alcohol Abuse and Alcoholism (NIAAA), and the National Heart, Lung, and Blood Institute (NHLBI). She is also a founding member, representing emergency medicine, on the American Board of Addiction Medicine. As a mentor, she has extensive experience cultivating the careers of junior faculty, residents, and students.
Dr. D’Onofrio has served as a principle investigator on several grants and has received RO1 funding from the National Institute on Alcohol Abuse and Alcoholism (for emergency department practitioner-performed brief interventions for harmful and hazardous drinking); the National Institute on Drug Abuse (for screening, intervention, treatment and referral of patients with opioid dependence); and several from the National Institutes of Health (NIH). She was also the recipient of a UO1 training grant from the Substance Abuse and Mental Health Services Administration (SAMSHA) that is designed to train physicians, medical students, nurses, social workers and counselors, about screening, brief intervention and referral.
Dr. D’Onofrio has a significant track record of peer-reviewed publications, including the New England Journal of Medicine, Annals of Emergency Medicine, Academic Emergency Medicine, Academic Medicine, and Substance Abuse. Her 2015 study published in the Journal of the American Medical Association (JAMA) was the first-known randomized trial comparing three treatment strategies for opioid-dependent patients receiving emergency care. The findings represented a shift in the screening and treatment of patients with chronic opioid dependence.
In addition, she is a national expert in women and heart disease and has been an integral part of the Yale-New Haven Hospital Women’s Heart Program. She completed a two-year U.S. Department of Health and Human Services (HHS) grant evaluating targeted interventions for women with cardiac risk factors in the ED Chest Pain Center. She is also a senior co-investigator on a large NHLBI grant studying young women with acute myocardial infarction.
She has received numerous awards for her leadership including the coveted Association of Medical Education and Research in Substance Abuse (AMERSA) mentoring award, the Hazelden Betty Ford Foundation Dan Anderson Research Award, which honors a single published article by a researcher who has advanced the scientific knowledge of addiction treatment and recovery; and the 2016 SAEM Advancement of Women in Academic Emergency Medicine Award which recognizes an SAEM member who has made significant contributions to the advancement of women in academic emergency medicine. In 2013, she became the first women to receive the SAEM Excellence in Research Award for her ground-breaking research, impact in the field, training of future researchers, and publication of academic research.
SAEM Awards and Plenary Sessions
Wednesday, May 16, 2018
The Awards precede the keynote address, and the Plenary Session will follow it.